Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pharmacoepidemiological Study to Examine Patient Characteristics, Drug Utilization Pattern and Crude Incidence Rates of Selected Outcomes in New Users of Ticagrelor, Clopidogrel and Prasugrel in National Swedish Registries

NCT01276275 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01276275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01276275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pharmacoepidemiological Study to Examine Patient Characteristics, Drug Utilization Pattern and Crude Incidence Rates of Selected Outcomes in New Users of Ticagrelor, Clopidogrel and Prasugrel in National Swedish Registries
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
April 30, 2015
Enrollment
7,200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding ,arrhythmias, heart failure, acute renal failure, acute liver failure, dyspnoea, gout